Intracellular sodium modulates the expression of angiotensin II subtype 2 receptor in PC12W cells.

Although the angiotensin II subtype 2 receptor (AT2-R) is expressed abundantly in the adrenal medulla, its physiological significance has not yet been determined. To obtain fundamental knowledge of the regulation of AT2-R expression in the adrenal medulla, we investigated the effects of modulating several ion channels on AT2-R expression in PC12W cells. Experiments were performed after 24 hours of serum depletion under subconfluent conditions. After 48 hours of treatment with various agonists or antagonists, the receptor density and mRNA level of AT2-Rs were quantified by 125I-[Sar1, Ile8]angiotensin II binding and Northern blot analysis. Ouabain (10 to 100 nmol/L) and insulin (10 to 100 nmol/L) dose-dependently increased receptor density and mRNA level. Analysis of the binding characteristics revealed that the ouabain-dependent increase in AT2-R levels was due to an increase in binding capacity without a change in the Kd value. These increases were blocked by lowering the Na+ concentration in the medium. A low concentration of the sodium ionophore monensin (10 nmol/L), the K+-channel blocker quinidine (10 micromol/L), and the ATP-sensitive K+-channel blockers tolbutamide (100 micromol/L) and glybenclamide (10 micromol/L) also significantly increased receptor density, but the ATP-sensitive K+-channel agonist cromakalim (100 micromol/L) decreased receptor density significantly (P<0.01). Nifedipine (10 micromol/L) decreased basal receptor density and completely blocked the increase in receptor density caused by these agents. The increase in receptor density caused by an increase in intracellular Na+ was accompanied by an increase in mRNA level, whereas the ATP-sensitive K+-channel blockers did not change mRNA level. Nifedipine slightly decreased mRNA level. These results suggest that AT2-R expression is sensitively regulated by intracellular cation levels. The change in intracellular Na+ level transcriptionally regulates AT2-R expression, whereas the K+-channel blocker-dependent upregulation appears to be at least in part posttranslational.

[1]  L. Meinel,et al.  Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. , 1997, Molecular endocrinology.

[2]  T. Unger,et al.  Extrarenal aspects of angiotensin II function. , 1997, European journal of endocrinology.

[3]  J. Gallo,et al.  Angiotensin II Induction of Neurite Outgrowth by AT2 Receptors in NG108-15 Cells , 1996, The Journal of Biological Chemistry.

[4]  T. Unger,et al.  The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells , 1996, Molecular and Cellular Endocrinology.

[5]  R. Carey,et al.  The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. , 1996, The Journal of clinical investigation.

[6]  A. Greene,et al.  Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. , 1996, Hypertension.

[7]  M. Horiuchi,et al.  Angiotensin II type 2 receptor mediates programmed cell death. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  T. Ichiki,et al.  Multiple growth factors modulate mRNA expression of angiotensin II type-2 receptor in R3T3 cells. , 1995, Circulation research.

[9]  R. Morishita,et al.  The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  B. Hogan,et al.  Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor , 1995, Nature.

[11]  M. Lo,et al.  Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats. , 1995, The Journal of clinical investigation.

[12]  M. Paul,et al.  The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. , 1995, The Journal of clinical investigation.

[13]  B. Buisson,et al.  A G Protein Is Involved in the Angiotensin AT Receptor Inhibition of the T-Type Calcium Current in Non-differentiated NG10815 Cells (*) , 1995, The Journal of Biological Chemistry.

[14]  D. Guo,et al.  Molecular biology of angiotensin II receptors: an overview. , 1994, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[15]  I. Siemens,et al.  Biochemical Characterization of Two Distinct Angiotensin AT2 Receptor Populations in Murine Neuroblastoma N1E‐115 Cells , 1994, Journal of neurochemistry.

[16]  T. Rogers,et al.  Angiotensin II stimulates the release of phospholipid-derived second messengers through multiple receptor subtypes in heart cells. , 1994, The Journal of biological chemistry.

[17]  H. Inui,et al.  Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. , 1993, The Journal of biological chemistry.

[18]  B. Livett,et al.  Noncholinergic control of adrenal catecholamine secretion. , 1993, Journal of anatomy.

[19]  H. Inui,et al.  Transduction of mitogenic activity of platelet-derived growth factor (PDGF) AB by PDGF-beta receptor without participation of PDGF-alpha receptor in vascular smooth muscle cells. , 1993, The Journal of biological chemistry.

[20]  H. Vijverberg,et al.  Tetraethylammonium ions block 5-HT3 receptor-mediated ion current at the agonist recognition site and prevent desensitization in cultured mouse neuroblastoma cells. , 1993, European journal of pharmacology.

[21]  P. Timmermans,et al.  Angiotensin II receptors and angiotensin II receptor antagonists. , 1993, Pharmacological reviews.

[22]  M. Perrone,et al.  Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin. , 1993, The American journal of physiology.

[23]  U. Steckelings,et al.  Angiotensin II Receptor Subtypes: Characterization, Signalling Mechanisms, and Possible Physiological Implications , 1993, Frontiers in Neuroendocrinology.

[24]  R. Speth.  [125I]CGP 42112 binding reveals differences between rat brain and adrenal AT2 receptor binding sites , 1993, Regulatory Peptides.

[25]  K. Kim,et al.  A role of retinoic acid in the regulation of the morphology and the levels of intermediate filament proteins and mRNAs in PC12 cells. , 1992, Experimental cell research.

[26]  F. F. Lam,et al.  Substance P-induced inflammation in the rat knee joint is mediated by neurokinin 1 (NK1) receptors , 1992, Regulatory Peptides.

[27]  P. Timmermans,et al.  Characterization of biochemical responses of angiotensin II (AT2) binding sites in the rat pheochromocytoma PC12W cells. , 1992, European journal of pharmacology.

[28]  E. Liu,et al.  Molecular characterization of angiotensin II type II receptors in rat pheochromocytoma cells , 1992, Peptides.

[29]  D. T. Dudley,et al.  Characterization of angiotensin II (AT2) binding sites in R3T3 cells. , 1991, Molecular pharmacology.

[30]  N. Jaiswal,et al.  Subtype 2 Angiotensin Receptors Mediate Prostaglandin Synthesis in Human Astrocytes , 1991, Hypertension.

[31]  P. Timmermans,et al.  Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). , 1990, The Journal of pharmacology and experimental therapeutics.

[32]  R. Speth,et al.  Discrimination of two angiotensin II receptor subtypes with a selective agonist analogue of angiotensin II, p-aminophenylalanine6 angiotensin II. , 1990, Biochemical and biophysical research communications.

[33]  E. Westhead,et al.  Cellular responses to Ca2+ from extracellular and intracellular sources are different as shown by simultaneous measurements of cytosolic Ca2+ and secretion from bovine chromaffin cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Timmermans,et al.  Identification of angiotensin II receptor subtypes. , 1989, Biochemical and biophysical research communications.

[35]  S. Whitebread,et al.  Preliminary biochemical characterization of two angiotensin II receptor subtypes. , 1989, Biochemical and biophysical research communications.

[36]  S. Bunn,et al.  Effects of angiotensin II on cultured, bovine adrenal medullary cells , 1989, Neuropeptides.

[37]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[38]  D. Aunis,et al.  Inactivation of the early calcium uptake and noradrenaline release evoked by potassium in cultured chromaffin cells. , 1986, Biochemical and biophysical research communications.

[39]  M. Vallotton,et al.  Solubilized adrenal angiotensin II receptors: studies on the site of action of sodium and calcium ions, and on the role of disulfide bridges , 1984, Molecular and Cellular Endocrinology.

[40]  M. Peach,et al.  Molecular actions of angiotensin. , 1981, Biochemical pharmacology.

[41]  L. Greene,et al.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[43]  G. Barsh,et al.  Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice , 1996, Nature.

[44]  C. Sumners,et al.  Modulation of the delayed rectifier K+ current in neurons by an angiotensin II type 2 receptor fragment. , 1995, The American journal of physiology.

[45]  Kyong-Tai Kim,et al.  Cellular responses to Ca 21 from extracellular and intracellular sources are different as shown by simultaneous measurements of cytosolic Ca 2 + and secretion from bovine chromaffin cells , 2022 .